Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry
![](https://www.corporatelawgroup.in/wp-content/uploads/2019/12/tablets-cocktail-cocktail-tablets-drugs-768x432-1.jpg)
The global biosimilars market is estimated to touch $15 billion by 2020. There is increased activity and growth in the biosimilars market globally with some of the best-selling biologics going off-patent.
To meet its global aspirations as a vital supplier of biosimilars, India must address some of the fundamental concerns that investors have about the Indian legal and regulatory framework for biopharmaceuticals.